Clinical Trials Sponsored by International Drug Development Institute

Total 315 results

Tools4Patient
International Drug Development Institute

Completed

A Proof of Concept Study to Investigate the Effect of a New Treatment in Patient With Chronic Pain

Osteoarthritis | Peripheral Neuropathies

France, Belgium
iSTAR Medical
International Drug Development Institute

Active, not recruiting

MINIject (MINI SO627) in Patients With Open Angle Glaucoma Using Single Operator Delivery Tool

Glaucoma, Open-Angle Glaucoma Eye

India, Panama
Tyrogenex
International Drug Development Institute; SynteractHCR

Terminated

X-82 to Treat Age-related Macular Degeneration

Eye Diseases | Macular Degeneration | Retinal Degeneration | Retinal Diseases | Age-Related Macular Degeneration (AMD) | Exudative Age-related Macular Degeneration | AMD | Macular Degeneration, Age-related, 10

United States
Jules Bordet Institute
Hoffmann-La Roche; Breast International Group; Institut Curie; International Drug...

Suspended

De-escalation Adjuvant Chemo in HER2+/ER-/Node-neg Early BC Patients Who Achieved pCR After Neoadjuvant Chemo & Dual HER2 Blockade (Decrescendo)

HER2-positive Breast Cancer | ER-Negative Breast Cancer | PR-Negative Breast Cancer | Node-negative Breast Cancer

Korea, Republic of, France, Israel, Belgium, Switzerland, Australia
NSABP Foundation Inc
Genentech, Inc.; International Drug Development Institute

Completed

Therapy With Bevacizumab (BEV), Epirubicin, and Cyclophosphamide Followed by Docetaxel Plus Trastuzumab and BEV Given as Neoadjuvant or Adjuvant Therapy for Women With Locally Advanced HER2 Positive Invasive Breast Cancer

Breast Cancer

United States, Canada
Steba Biotech S.A.
International Drug Development Institute; PrimeVigilance LTD

Terminated

Study of Erectile Dysfunction, Urinary Incontinence and Related QoL After TOOKAD® VTP for Low Risk Prostate Cancer

Low Risk Prostate Cancer

France
Steba Biotech S.A.
ICON plc; International Drug Development Institute

Completed

European Randomised Study of TOOKAD® Soluble for Prostate Cancer vs Active Surveillance. Post Study Follow-up

Cancer of the Prostate

Netherlands, Spain, France, Germany, United Kingdom, Finland, Italy, Sweden
Vifor (International) Inc.
Labcorp Drug Development Inc

Withdrawn

Efficacy and Safety Study of Multiple Doses of VIT-2763 in Adults With Transfusion-dependent Beta-thalassemia

Beta-Thalassemia

United States, Bulgaria, Israel
NSABP Foundation Inc
Hoffmann-La Roche; Genentech, Inc.; International Drug Development Institute

Terminated

Study of Bevacizumab Combined With Capecitabine and Either Oxaliplatin or Irinotecan as First Course of Treatment for Patients With Colorectal Cancer That Has Spread Beyond the Colon

Colorectal Neoplasms

United States
NSABP Foundation Inc
Hoffmann-La Roche; Genentech, Inc.; International Drug Development Institute

Completed

Therapy With Bevacizumab (BEV), Doxorubicin, and Cyclophosphamide Followed by BEV, Docetaxel, and Capecitabine Before Surgery Followed by BEV Alone After Surgery for Women With Locally Advanced Breast Cancer

Breast Cancer

United States
Translational Drug Development
Translational Genomics Research Institute

Active, not recruiting

Study Evaluating the Ketogenic Diet in Patients With Metastatic Pancreatic Cancer

Metastatic Pancreatic Ductal Adenocarcinoma

United States
RTI International
National Institute on Drug Abuse (NIDA)

Unknown

Preventing Opioid Overdose Mortality in the United States

Opioid Overdose

United States
RTI International
National Institute on Drug Abuse (NIDA)

Completed

Pregnant Women's CoOp

HIV

United States
RTI International
National Institute on Drug Abuse (NIDA)

Terminated

First in Humans Study of JDTic

Cocaine Dependence

United States
RTI International
National Institute on Drug Abuse (NIDA)

Completed

Substance Abuse Treatment to HIV Care (SAT2HIV): The Implementation & Sustainment Facilitation Experiment

Substance Use

United States
RTI International
National Institute on Drug Abuse (NIDA)

Completed

Substance Abuse Treatment to HIV Care (SAT2HIV): The Motivational Interviewing-based Brief Intervention Experiment

Substance Use

United States
RTI International
National Institute on Drug Abuse (NIDA)

Completed

Computer-Assisted Tailored Cue-card Health [CATCH] Study (CATCH)

Hepatitis, Viral, Human | Human Immunodeficiency Virus | STDs

United States
RTI International
National Institute on Drug Abuse (NIDA)

Completed

Safety, Tolerability, and Pharmacokinetics of Single, Escalating Oral Doses of RTI-336 in Healthy, Male Subjects

Cocaine Dependence

United States
Florida International University
National Institute on Drug Abuse (NIDA)

Completed

Zinc Therapy in HIV Infected Individuals Who Abuse Drugs

Substance-Related Disorders | HIV Infections

United States
EDDC (Experimental Drug Development Centre), A*STAR...
Chiltern International Inc.

Withdrawn

Evaluation of ETC-1907206 With Dasatinib in Advanced Haematologic Malignancies

Ph+ Acute Lymphoblastic Leukemia (Ph+ALL) | Ph- Acute Lymphoblastic Leukemia (Ph-ALL) | Chronic Myeloid Leukemia Accelerated Phase (CML-AP, Ph+) | Chronic Myeloid Leukemia Blast Crisis (CML-BC, Ph+)

United States, Singapore
Florida International University
National Institute on Drug Abuse (NIDA)

Recruiting

Supporting Treatment Adherence for Resilience and Thriving (START) (START)

Adherence, Medication | HIV-1-infection | Stimulant Use

United States
Florida International University
National Institute on Drug Abuse (NIDA)

Completed

The Effects of Nutritional Supplementation and Drug Abuse on HIV

Substance-Related Disorders | HIV Infections

Botswana
National Development and Research Institutes, Inc.
National Institute on Drug Abuse (NIDA)

Unknown

Mobile Psychosocial Interventions for MMT Clients (MobileMMT)

Substance Abuse | Opioid Abuse

United States
National Development and Research Institutes, Inc.
National Institute on Drug Abuse (NIDA)

Unknown

Transmission Reduction Intervention Project (TRIP)

HIV

United States, Greece, Ukraine
National Development and Research Institutes, Inc.
National Institute on Drug Abuse (NIDA)

Unknown

Comparative Effectiveness of Web-based Versus Traditional Adolescent HIV Prevention

HIV Infections | Hepatitis | Sexually Transmitted Infections

United States
National Development and Research Institutes, Inc.
National Institute on Drug Abuse (NIDA)

Completed

Colorado Women's TC Project

Substance-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
National Development and Research Institutes, Inc.

Completed

Effectiveness of Self-Help for Dually-Diagnosed Persons - 1

Substance-Related Disorders | Mental Disorders | Dual Diagnosis

United States
National Development and Research Institutes, Inc.
National Institute on Drug Abuse (NIDA)

Completed

Technological Innovations in Behavioral Treatments for Cigarette Smoking

Cigarette Smoking

United States
National Development and Research Institutes, Inc.
National Institute on Drug Abuse (NIDA)

Completed

Internet-based Group Contingency Management to Promote Smoking Abstinence

Cigarette Smoking

United States
National Development and Research Institutes, Inc.
National Institute on Drug Abuse (NIDA)

Completed

HIV Prevention Intervention for Couples

Acquired Immunodeficiency Syndrome

United States
National Development and Research Institutes, Inc.
National Institute on Drug Abuse (NIDA)

Completed

Re-Entry MTC for Offenders With MICA Disorders

Substance-Related Disorders | Mental Disorders

United States
Friends Research Institute, Inc.
National Institute on Drug Abuse (NIDA); RTI International

Completed

SBIRT Implementation for Adolescents in Urban Federally Qualified Health Centers (ST@T)

Tobacco Use Disorder | Alcohol-induced Disorders | Drug Users

United States
International Food Policy Research Institute
Helen Keller International; Foreign Affairs, Trade and Development, Canada

Completed

Creating Homestead Agriculture for Nutrition and Gender Equity (CHANGE) in Burkina Faso (CHANGE)

Anemia | Growth Retardation

Burkina Faso
International Centre for Diarrhoeal Disease Research...
Department for International Development, United Kingdom; University of Sydney and other collaborators

Completed

Evaluating Bundling of Nutrition-specific Interventions

Stunting in Under-2 Children

Bangladesh
Makerere University
Karolinska Institutet; Swedish International Development Cooperation Agency...

Unknown

Artemether/ Lumefantrine: A Study of the Effect of Local Food on Pharmacokinetics and Population Pharmacokinetics

Malaria, Falciparum

Uganda
The International Livestock Research Institute...
Bill and Melinda Gates Foundation; Department for International Development... and other collaborators

Terminated

MoreMilk Project: Milk Safety and Child Nutrition Impacts of a Training Scheme for Dairy Vendors in Nairobi, Kenya

Food Safety | Child Nutrition

Kenya
InBios International, Inc.
Biomedical Advanced Research and Development Authority; Fast-Track Drugs &...

Completed

Evaluation of the Clinical Performance of the ZIKV Detect™ 2.0 IgM Capture ELISA

Zika Virus Infection

United States
InBios International, Inc.
Biomedical Advanced Research and Development Authority; Fast-Track Drugs &...

Completed

Evaluation of the Clinical Specificity of the Active Anthrax Detect™ Plus (AAD Plus) Lateral Flow Immunoassay (LFI)

Anthrax

United States
International Centre for Diarrhoeal Disease Research...
Karolinska Institutet; Swedish International Development Cooperation Agency...

Completed

Prebiotic in Preventing Low Birth Weight

Birth Weight <2500gm | Genitourinary Tract Infection

Bangladesh
International Centre for Diarrhoeal Disease Research...
Karolinska Institutet; Swedish International Development Cooperation Agency...

Completed

Therapeutic Induction of Endogenous Antibiotics

Shigellosis

Bangladesh
Johns Hopkins University
National Institute on Drug Abuse (NIDA); RTI International; National Institute...

Completed

Differences in Cannabis Impairment and Its Measurement Due to Route of Administration

Behavioral Pharmacology of Cannabis

United States
Boston Medical Center
Boston University; National Institute on Drug Abuse (NIDA); RTI International

Completed

Assessing Screening Plus Brief Intervention's Resulting Efficacy (ASPIRE) to Stop Drug Use (ASPIRE)

Drug Abuse | Drug Usage | Drug Dependence

United States
National Institute on Drug Abuse (NIDA)
VA Office of Research and Development

Completed

Selegiline for Smoking Cessation - 1

Nicotine Dependence

United States
National Institute on Drug Abuse (NIDA)
VA Office of Research and Development

Completed

M-CPP and Fenfluramine in Cocaine Addicts - 3

Cocaine-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
VA Office of Research and Development

Terminated

Predictive Values of Serotonergic Alterations for Outcome - 2

Cocaine-Related Disorders

United States
The Aquaya Institute
United States Agency for International Development (USAID); Tetratech

Completed

Research on the Impact of Targeted Subsidies Within Open Defecation Free (ODF) Communities

Sanitation

Ghana
National Institute on Drug Abuse (NIDA)
VA Office of Research and Development

Completed

Phase 2, Multi-Center Trial of Modafinil for Methamphetamine Dependence

Methamphetamine Dependence

United States
National Institute on Drug Abuse (NIDA)
VA Office of Research and Development

Completed

Pharmacotherapy and Intensive Treatment - 2

Substance-Related Disorders | Cocaine-Related Disorders

United States
National Development and Research Institutes, Inc.
National Institute on Drug Abuse (NIDA); Beth Israel Medical Center

Completed

Web-based Cognitive-behavior Therapy (CBT) for Opioid-treated, Chronic Pain Patients With Aberrant Behavior (WebCBTPain)

Chronic Pain

United States
Doug Parkerson
United States Agency for International Development (USAID); AVSI Foundation

Completed

Impact of Graduating to Resilience on Child Development in Uganda

Child Development

Uganda

Clinical Trials Sponsored by International Drug Development Institute

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Israel

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations